FDA OKs Adjuvant Ribociclib in Earlier Stage Breast Cancer

Source link : https://www.yourblogdomain.com/2024/09/19/fda-oks-adjuvant-ribociclib-in-earlier-stage-breast-cancer/

Source link : https://www.newshealth.biz/health-news/fda-oks-adjuvant-ribociclib-in-earlier-stage-breast-cancer/ The US Food and Drug Administration (FDA) approved ribociclib (Kisqali, Novartis) in combination with an aromatase inhibitor for adult patients with HR-positive, HER2-negative stages II and III breast cancer at high-risk for recurrence following surgery.  FDA also approved ribociclib and the aromatase inhibitor letrozole packaged together (Kisqali Femara Co-Pack, Novartis) for […]

—-

Author : yourblogdomain

Publish date : 2024-09-19 11:08:51

Copyright for syndicated content belongs to the linked Source.